Earlier quoted context omitted.
Even if you try to account for the overall R&D cost, DeepMind isn't that large an organization by the standards of biomedical research. It's very big and well funded for a computer science research organization, yes, and most CS departments can't match its resources. But the NIH budget is $40 billion, and private pharmaceutical companies do another $80 billion in annual R&D. It's interesting that this kind of breakth…
DeepMind is taking advantage of NIH's funding. For example, Anfinsen who demonstrated that proteins fold spontaneously and reproducibly ( https://en.wikipedia.org/wiki/Anfinsen%27s_dogma ) ran a lab at NIH. Levinthal (who postulated an early and easily refutable model of protein folding) was funded by NIH for decades. Most of the competitors at CASP are supported by NIH and its investments have contributed to the mod…
What I meant to focus on was that I think DeepMind has less of a pure money/scale advantage in this area than in some others. In something like Go or Atari game-playing, there are many academic groups researching similar things, but their resources are laughably small compared to what DeepMind threw at it. So you might argue that they got good results there in part because they directed 1000x the personnel and compute at the problem compared to what any academic group could afford. In biomed though, their peers in academia and industry are also pretty well-funded.